Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Partow Kebriaei

Showing results (131-140 of 346) with videos related to

Pageof 35
Sort By:
Transplantation and Cellular Therapy|July 5, 2023
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid LeukemiaMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2010
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDSBorje S Andersson, Benigno C Valdez, Marcos de Lima, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2016
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cellsLenka V Hurton, Harjeet Singh, Amer M Najjar, et al.
Leukemia & Lymphoma|February 26, 2008
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis productsMelinda K Gordon, Dorie Sher, Theodore Karrison, et al.
Bone Marrow Transplantation|October 20, 2018
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantationMithun Vinod Shah, Rima M Saliba, Gabriela Rondon, et al.
Cancer|September 30, 2016
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myelomaIdrees Mian, Denái R Milton, Nina Shah, et al.
Blood Vessels, Thrombosis & Hemostasis|January 8, 2026
Automated natural language processing to identify venous thromboembolism from diagnostic imaging reportsNaveen Subramanian, Hector Garcia Pleitez, Daniel Nguyen, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 13, 2015
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell TransplantationSyed M Kazmi, Maliha Nusrat, Hilal Gunaydin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 27, 2011
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomesPartow Kebriaei, Rima Saliba, Gabriela Rondon, et al.
The Lancet. Oncology|February 24, 2012
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 studyHagop Kantarjian, Deborah Thomas, Jeffrey Jorgensen, et al.
Pageof 35

Showing results (131-140 of 346) with videos related to

Sort By:
Pageof 35
Transplantation and Cellular Therapy|July 5, 2023
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid LeukemiaMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 16, 2010
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDSBorje S Andersson, Benigno C Valdez, Marcos de Lima, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2016
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cellsLenka V Hurton, Harjeet Singh, Amer M Najjar, et al.
Leukemia & Lymphoma|February 26, 2008
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis productsMelinda K Gordon, Dorie Sher, Theodore Karrison, et al.
Bone Marrow Transplantation|October 20, 2018
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantationMithun Vinod Shah, Rima M Saliba, Gabriela Rondon, et al.
Cancer|September 30, 2016
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myelomaIdrees Mian, Denái R Milton, Nina Shah, et al.
Blood Vessels, Thrombosis & Hemostasis|January 8, 2026
Automated natural language processing to identify venous thromboembolism from diagnostic imaging reportsNaveen Subramanian, Hector Garcia Pleitez, Daniel Nguyen, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 13, 2015
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell TransplantationSyed M Kazmi, Maliha Nusrat, Hilal Gunaydin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 27, 2011
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomesPartow Kebriaei, Rima Saliba, Gabriela Rondon, et al.
The Lancet. Oncology|February 24, 2012
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 studyHagop Kantarjian, Deborah Thomas, Jeffrey Jorgensen, et al.
Pageof 35